Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBT (2016 - 2025)

Historic EBT for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to -$679968.0.

  • cbdMD's EBT fell 34500.81% to -$679968.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 4484.23%. This contributed to the annual value of -$2.0 million for FY2025, which is 4484.24% up from last year.
  • Per cbdMD's latest filing, its EBT stood at -$679968.0 for Q3 2025, which was down 34500.81% from -$895272.0 recorded in Q2 2025.
  • Over the past 5 years, cbdMD's EBT peaked at $1.6 million during Q2 2021, and registered a low of -$31.6 million during Q2 2022.
  • For the 5-year period, cbdMD's EBT averaged around -$6.0 million, with its median value being -$1.8 million (2023).
  • Its EBT has fluctuated over the past 5 years, first tumbled by 202857.25% in 2022, then soared by 12596.79% in 2024.
  • Over the past 5 years, cbdMD's EBT (Quarter) stood at -$19.2 million in 2021, then skyrocketed by 79.35% to -$4.0 million in 2022, then surged by 74.81% to -$996501.0 in 2023, then surged by 101.51% to $15095.0 in 2024, then crashed by 4604.59% to -$679968.0 in 2025.
  • Its last three reported values are -$679968.0 in Q3 2025, -$895272.0 for Q2 2025, and -$480757.0 during Q1 2025.